Aortitis Associated with Prophylactic Short-acting Granulocyte Colony-stimulating Factor Administration: A Case Report and Review of the Literature

被引：3

作者：

Masuda, Yasutaka

Oyama, Takashi

Nakazaki, Kumi

Nakai, Yudai

Sasaki, Ken

Matsuda, Kensuke

Masamoto, Yosuke

Kurokawa, Mineo ^{[1
]}

机构：

[1] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo, Japan

来源：

INTERNAL MEDICINE | 2023年 / 62卷 / 11期

关键词：

granulocyte colony-stimulating factor; short-acting G-CSF; long-acting G-CSF; aortitis; prophylactic treatment; non-Hodgkin lymphoma; DAILY FILGRASTIM; OPEN-LABEL; CHEMOTHERAPY; PEGFILGRASTIM; NEUTROPENIA; RECOMMENDATIONS; LYMPHOMA;

D O I：

10.2169/internalmedicine.0599-22

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We herein report an 83-year-old woman with filgrastim-associated aortitis during chemotherapy for re-lapsed diffuse large B-cell lymphoma. She had been treated with filgrastim as a prophylaxis for neutropenia during the fourth cycle of chemotherapy from day 9 to 18. On day 21, she developed a fever. Contrast -enhanced computed tomography revealed aortitis of the descending aorta. The fever abated with non-steroidal anti-inflammatory drug treatment. A literature review identified a small number of aortitis cases all caused by prophylactic use of granulocyte colony-stimulating factors (G-CSFs), among which short-acting filgrastim was rarely encountered. The present and previous findings imply a possible relationship between aortitis and prophylactic G-CSF usage.

引用

页码：1647 / 1652

页数：6

共 33 条

[1] EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours [J].

Aapro, M. S. ;

Cameron, D. A. ;

Pettengell, R. ;

Bohlius, J. ;

Crawford, J. ;

Ellis, M. ;

Kearney, N. ;

Lyman, G. H. ;

Tjan-Heijnen, V. C. ;

Walewski, J. ;

Weber, D. C. ;

Zielinski, C. .

EUROPEAN JOURNAL OF CANCER, 2006, 42 (15) :2433-2453

[2] Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification [J].

Cheson, Bruce D. ;

Fisher, Richard I. ;

Barrington, Sally F. ;

Cavalli, Franco ;

Schwartz, Lawrence H. ;

Zucca, Emanuele ;

Lister, T. Andrew .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3059-+

[3]

Cornes P, 2018, ADV THER, V35, P1816, DOI 10.1007/s12325-018-0798-6

[4]

D'Souza Anita, 2008, Transfus Med Rev, V22, P280, DOI 10.1016/j.tmrv.2008.05.005

[5]

DELGADO C, 1992, CRIT REV THER DRUG, V9, P249

[6] EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR ON NEUTROPENIA AND ASSOCIATED MORBIDITY DUE TO CHEMOTHERAPY FOR TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM [J].

GABRILOVE, JL ;

JAKUBOWSKI, A ;

SCHER, H ;

STERNBERG, C ;

WONG, G ;

GROUS, J ;

YAGODA, A ;

FAIN, K ;

MOORE, MAS ;

CLARKSON, B ;

OETTGEN, HF ;

ALTON, K ;

WELTE, K ;

SOUZA, L .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (22) :1414-1422

[7] Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma [J].

Grigg, A ;

Solal-Celigny, P ;

Hoskin, P ;

Taylor, K ;

McMillan, A ;

Forstpointner, R ;

Bacon, P ;

Renwick, J ;

Hiddemann, W .

LEUKEMIA & LYMPHOMA, 2003, 44 (09) :1503-1508

[8]

Ito Yuta, 2017, Rinsho Ketsueki, V58, P2238, DOI 10.11406/rinketsu.58.2238

[9] Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy [J].

Johnston, E ;

Crawford, J ;

Blackwell, S ;

Bjurstrom, T ;

Lockbaum, P ;

Roskos, L ;

Yang, BB ;

Gardner, S ;

Miller-Messana, MA ;

Shoemaker, D ;

Garst, J ;

Schwab, G .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (13) :2522-2528

[10] Takayasu arteritis: a review [J].

Johnston, SL ;

Lock, RJ ;

Gompels, MM .

JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (07) :481-486

← 1 2 3 4 →